It is worth noting that the enhanced survival observed in patients with NTDT may have been influenced by the relatively high proportion of individuals with Hb H disease (301 out of 789 patients, 38.1%), who generally present with milder anaemia and a less severe disease spectrum. The gene discussed is GSTM1; the disease is anemia.